Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Rubicon Organics Inc

Healthcare CA ROMJ

0.44CAD
0.005(1.15%)

Last update at 2026-06-05T17:33:00Z

Day Range

0.430.47
LowHigh

52 Week Range

0.390.73
LowHigh

Fundamentals

  • Previous Close 0.43
  • Market Cap38.52M
  • Volume85500
  • P/E Ratio28.50
  • Dividend Yield-%
  • EBITDA4.78M
  • Revenue TTM59.45M
  • Revenue Per Share TTM0.90
  • Gross Profit TTM 22.14M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1.05M -2.56241M -1.82354M -3.85585M -14.52074M
Minority interest - - - - -
Net income 1.05M -2.56241M -1.82354M -3.85585M -14.52074M
Selling general administrative 20.12M 16.37M 13.93M 16.07M 14.58M
Selling and marketing expenses - - - - -
Gross profit 22.14M 15.42M 13.14M 13.81M 1.51M
Reconciled depreciation 3.36M 3.27M 3.12M 3.05M 2.40M
Ebit - - - - -13.07964M
Ebitda - - - 0.22M -10.86915M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 1.82M -1.16988M -1.08344M -2.58868M -13.34100M
Other operating expenses - - - - -
Interest expense 0.71M 1.15M 1.10M 1.02M 1.26M
Tax provision - - - - -
Interest income - - - - 0.08M
Net interest income -0.70700M -1.14958M -1.10126M -1.02276M -1.17151M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 59.45M 48.70M 40.12M 35.52M 22.61M
Total operating expenses 57.62M 49.87M 41.20M 38.11M 35.95M
Cost of revenue 37.31M 33.28M 26.98M 21.71M 21.10M
Total other income expense net -0.06700M -0.24295M 0.36M -0.24441M -0.00823M
Discontinued operations - - - - -
Net income from continuing ops 1.05M -2.56241M -1.82354M -3.85585M -14.52074M
Net income applicable to common shares - - - - -14.52074M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 66.89M 56.61M 54.89M 56.11M 54.84M
Intangible assets 2.38M 2.38M 2.38M 2.38M 1.88M
Earning assets - - - - -
Other current assets - - - - 0.15M
Total liab 22.84M 19.21M 17.00M 17.77M 15.94M
Total stockholder equity 44.06M 37.40M 37.89M 38.33M 38.90M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - - - 107.21M
Capital stock 111.93M 108.30M 107.79M 107.61M 107.21M
Retained earnings -93.03500M -94.08551M -91.52311M -89.69957M -85.84373M
Other liab - - - - -
Good will - - - - -
Other assets - - - - 0.48M
Cash 3.99M 9.86M 9.78M 8.29M 11.58M
Cash and equivalents - - - - -
Total current liabilities 12.19M 10.71M 16.91M 8.37M 6.94M
Current deferred revenue - - - - -
Net debt 8.08M - 0.48M 1.87M -
Short term debt - - - - -
Short long term debt 1.72M 1.32M 10.26M 0.76M 0.66M
Short long term debt total - - - - -
Other stockholder equity - - - - 17.54M
Property plant equipment - - - - 25.30M
Total current assets 35.83M 30.65M 27.04M 27.69M 27.17M
Long term investments - - - - -
Net tangible assets - - - - 37.02M
Short term investments - - - - -
Net receivables 9.05M 5.62M 3.32M 4.77M 4.16M
Long term debt 10.35M 8.48M - 9.40M 8.95M
Inventory 19.48M 12.57M 11.28M 12.66M 10.61M
Accounts payable 1.52M 1.78M 1.15M 0.68M 1.57M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 31.06M 25.96M 27.85M 28.41M 27.67M
Capital lease obligations 0.35M 0.09M 0.14M 0.06M 0.21M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -1.54547M -3.38268M -4.45086M -5.49732M
Change to liabilities - - - - -0.39168M
Total cashflows from investing activities - - - - -5.49732M
Net borrowings 2.16M -1.47437M -0.10700M - -4.19169M
Total cash from financing activities 5.67M -1.77409M -0.82934M -0.83856M 15.30M
Change to operating activities - - - - 0.57M
Net income 1.05M -2.56241M -1.82354M -3.85585M -14.52074M
Change in cash -5.86800M 0.07M 2.56M -3.28933M -0.55302M
Begin period cash flow 9.86M 9.78M 6.84M 11.58M 12.14M
End period cash flow 3.99M 9.86M 9.42M 8.29M 11.58M
Total cash from operating activities -3.03900M 3.40M 6.79M 1.95M -10.44234M
Issuance of capital stock 4.16M - - 0.00000M 21.22M
Depreciation 3.36M 3.27M 3.12M 3.05M 2.40M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -4.15000M -1.21325M 0.67M -0.44611M -1.13311M
Change to account receivables -3.46700M -2.49167M 0.86M -0.62562M -1.58647M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -2.33118M
Change to netincome - - - - 4.22M
Capital expenditures 8.42M 1.55M 3.38M 4.45M 5.50M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -7.00500M -0.57776M 2.33M 0.08M -2.53648M
Stock based compensation 1.44M 2.07M 1.76M 3.04M 2.14M
Other non cash items -1.95900M 1.03M 6.69M 0.89M 2.05M
Free cash flow -11.45500M 1.85M 3.41M -2.49886M -15.93966M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ROMJ
Rubicon Organics Inc		 0.005 1.15% 0.44 28.50 38.02 0.65 0.87 0.79 9.17
RX
Biosyent Inc.		 -0.3 2.14% 13.70 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -0.005 4.17% 0.12 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 - -% 0.50 - - 108.48 4.41 140.29 -4.258
LSL
LSL Pharma Group Inc.		 - -% 0.33 20.75 - 1.88 1.89 2.85 10.19

Reports Covered

Stock Research & News

View All

Profile

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in jar, bag, pre-rolls, edible, poutine sauce mix, milled flower, soft gels, hash, blunt, gummies, flower variety pack, pot brownies, resin vape, relief stick, cool stick, and oil formats. It sells its products under the Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, LAB THEORY, and Wildflower brand names. The company was formerly known as West Coast Land Corporation and changed its name to Rubicon Organics Inc. in May 2018. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Rubicon Organics Inc

744 West Hastings Street, Vancouver, BC, Canada, V6C 1A5

Key Executives

Name Title Year Born
Mr. Jesse McConnell M.A. Co-Founder, CEO & Director 1977
Ms. Margaret Ruth Brodie C.A., CPA CFO & Director 1978
Mr. Peter Dierx VP of Operations NA
Mr. Benoit Pinsonneault VP of Sales NA
Ms. Monika Mascitti VP of People NA
Ms. Melanie Ramsey Chief Commercial Officer & Director NA
Ms. Margaret Ruth Brodie C.A., CPA CEO & Director 1979
Ms. Melanie Ramsey Chief Commercial Officer NA
Ms. Janis Risbin CFO & Company Secretary NA
Mr. Tyler Perkins Director of Operations & Facilities NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.